Enhancements    

VALIDITY OF PCR AND OTHER BIOMARKERS FOR ASSESSING PARASITOLOGICAL CURE IN CHAGAS DISEASE

VALIDITY OF PCR AND OTHER BIOMARKERS FOR ASSESSING PARASITOLOGICAL CURE IN CHAGAS DISEASE
PI: Igor Almeida
Sponsor: DRUGS FOR NEGLECTED DISEASES INITIATIVE
Biological Sciences
Amount awarded: $33,065

Funding for this project will be used for the analysis of lytic antibodies against T. cruzi in non-human primates serum samples provided by the Texas Biomedical Research Institute. Previous and current studies of Dr. Almeida’s group and of others have shown that tGPI-mucin/CL-ELISA can accurately diagnose Chagas disease and follow-up the cure in benznidazole-treated Chagasic patients.

Posting date: Fri, 09/23/2016

Award start date: Sun, 05/15/2016
Award end date: Mon, 08/15/2016